David Hovland
Chief Regulatory Officer @ Eledon Pharmaceuticals
About David Hovland
David Hovland is the Chief Regulatory Officer with over 20 years of R&D experience in the pharmaceutical industry, contributing to the development and registration of various pharmaceutical products.
Known information
David Hovland serves as the Chief Regulatory Officer and brings over 20 years of research and development experience in the pharmaceutical industry. He has significantly contributed to the global development and registration of multiple small and large molecule pharmaceutical products. Before joining Eledon, he was the Senior Vice President of Global Regulatory Affairs and Quality at Urovant Sciences. He also held various leadership roles within the Global Regulatory Affairs organization at Allergan, including Regulatory Affairs Therapeutic Area Head for Neurology, Urology, and Dermatology. Additionally, Hovland has experience working in Amgen’s Global Regulatory Affairs and Safety organization. He earned a Ph.D. in Environmental Health Sciences from the School of Public Health at the University of California, Los Angeles, and holds a B.S. in Bioresource Sciences from the College of Natural Resources at the University of California, Berkeley.
About Eledon Pharmaceuticals
Eledon Pharmaceuticals develops immune-modulating therapies for life-threatening conditions, with a focus on their lead investigational product, tegoprubart. The company is headquartered in Irvine, California, and conducts clinical trials in kidney transplantation, xenotransplantation, and ALS.